Canada - engleză - Health Canada

sanofi pasteur inc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b 15mcg - vaccines

Canada - engleză - Health Canada

sanofi pasteur inc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b 15mcg - vaccines

Canada - engleză - Health Canada

astrazeneca canada inc - influenza virus type a (h1n1); influenza virus type a (h3n2); influenza virus type b (victoria); influenza virus type b (yamagata) - spray - 32000000ffu; 32000000ffu; 32000000ffu; 32000000ffu - influenza virus type a (h1n1) 32000000ffu; influenza virus type a (h3n2) 32000000ffu; influenza virus type b (victoria) 32000000ffu; influenza virus type b (yamagata) 32000000ffu - vaccines

Canada - engleză - Health Canada

kvr pharmaceuticals inc. - desmopressin acetate - solution - 4mcg - desmopressin acetate 4mcg - pituitary

Canada - engleză - Health Canada

panda pharmaceuticals inc. - methacholine chloride - powder for solution - 100mg - methacholine chloride 100mg - other diagnostic agents

Canada - engleză - Health Canada

panda pharmaceuticals inc. - methacholine chloride - powder for solution - 160mg - methacholine chloride 160mg - other diagnostic agents

Canada - engleză - Health Canada

panda pharmaceuticals inc. - methacholine chloride - powder for solution - 320mg - methacholine chloride 320mg - other diagnostic agents

Canada - engleză - Health Canada

panda pharmaceuticals inc. - methacholine chloride - powder for solution - 1280mg - methacholine chloride 1280mg - other diagnostic agents

Canada - engleză - Health Canada

panda pharmaceuticals inc. - methacholine chloride - powder for solution - 1600mg - methacholine chloride 1600mg - other diagnostic agents

Israel - engleză - Ministry of Health

glaxo smith kline (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - suspension for injection - b/phuket/3073/2013 (b/yamagata lineage)-like virus 30 mcg ha / 1 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 30 mcg ha / 1 ml; a/darwin/9/2021 (h3n2)-like virus 30 mcg ha / 1 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 30 mcg ha / 1 ml - influenza, inactivated, split virus or surface antigen - fluarix tetra is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine.